CVS Health Corporation (CVS) earnings
CVS earnings moved a median of +0.33% by the close. Quarterly and annual CVS reports and results, each read against the price at its own news timestamp. Back to the CVS overview →
34 measured CVS earnings events.
Where these CVS earnings landedvs 34 measured CVS earnings reactions
| Middle 50% of CVS earnings reactions | -1.80% to +1.84% |
|---|---|
| Median reaction (to close) | +0.33% |
| Measured reactions | 34 |
Point-in-time · zero look-ahead
Half of the 34 CVS earnings events with a measured close landed between -1.80% and +1.84%; 56% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| CVS Health to hold third quarter 2026 earnings conference call | Press release | -0.19% | +0.37% | |
| CVS HEALTH CORPORATION REPORTS STRONG SECOND QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE | Press release | +2.72% | +5.33% | |
| Form 10-Q CVS HEALTH Corp For: Jun 30 | SEC filing · Form 10-Q | +2.72% | +5.33% | |
| CVS Health to hold second quarter 2026 earnings conference call | Press release | -0.51% | -2.83% | |
| CVS HEALTH CORPORATION REPORTS STRONG FIRST QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE | Press release | +2.47% | +1.59% | |
| Form 10-Q CVS HEALTH Corp For: Mar 31 | SEC filing · Form 10-Q | +2.47% | +1.59% | |
| CVS Health to hold first quarter 2026 earnings conference call | Press release | -0.46% | -0.29% | |
| Form 10-K CVS HEALTH Corp For: Dec 31 | SEC filing · Form 10-K | +3.43% | +3.35% | |
| CVS Health to hold fourth quarter and full year 2025 earnings conference call | Press release | -0.11% | +2.62% | |
| CVS Health to hold fourth quarter and full year 2025 earnings conference call | Press release | -0.38% | -0.63% | |
| CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE | Press release | +3.33% | -1.88% | |
| Form 10-Q CVS HEALTH Corp For: Sep 30 | SEC filing · Form 10-Q | +3.33% | -1.88% | |
| CVS Health to hold third quarter 2025 earnings conference call | Press release | +0.21% | +0.21% | |
| CVS HEALTH CORPORATION REPORTS SECOND QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE | Press release | +0.11% | -4.94% | |
| Form 10-Q CVS HEALTH Corp For: Jun 30 | SEC filing · Form 10-Q | +0.11% | -4.94% | |
| CVS Health to hold second quarter 2025 earnings conference call | Press release | +0.34% | +0.34% | |
| CVS HEALTH CORPORATION REPORTS FIRST QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE | Press release | -3.25% | -3.88% | |
| Form 10-Q CVS HEALTH Corp For: Mar 31 | SEC filing · Form 10-Q | -3.25% | -3.88% | |
| CVS Health to hold first quarter 2025 earnings conference call | Press release | +2.10% | +1.92% | |
| Form 10-K CVS HEALTH Corp For: Dec 31 | SEC filing · Form 10-K | +2.14% | +3.69% | |
| CVS Health to hold fourth quarter and full year 2024 earnings conference call | Press release | +0.10% | +2.34% | |
| CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2024 RESULTS | Press release | +0.45% | -0.45% | |
| Form 10-Q CVS HEALTH Corp For: Sep 30 | SEC filing · Form 10-Q | +0.45% | -0.45% | |
| CVS Health to hold third quarter 2024 earnings conference call | Press release | +1.07% | +1.52% | |
| CVS HEALTH CORPORATION REPORTS SECOND QUARTER 2024 RESULTS AND REVISES FULL-YEAR 2024 GUIDANCE | Press release | -0.02% | -2.64% | |
| Form 10-Q CVS HEALTH Corp For: Jun 30 | SEC filing · Form 10-Q | -0.02% | -2.64% | |
| CVS Health to hold second quarter 2024 earnings conference call | Press release | +0.21% | +0.42% | |
| CVS HEALTH CORPORATION REPORTS FIRST QUARTER 2024 RESULTS AND REVISES FULL-YEAR 2024 GUIDANCE | Press release | +0.11% | +1.62% | |
| Form 10-Q CVS HEALTH Corp For: Mar 31 | SEC filing · Form 10-Q | +0.11% | +1.62% | |
| CVS Health to hold first quarter 2024 earnings conference call | Press release | -0.18% | -0.21% | |
| Form 10-K CVS HEALTH Corp For: Dec 31 | SEC filing · Form 10-K | +0.81% | +0.33% | |
| CVS Health to Hold Fourth Quarter and Full Year 2023 Earnings Conference Call | Press release | -0.46% | -1.58% | |
| CVS Health reports third quarter results | Press release | -0.06% | +4.77% | |
| Form 10-Q CVS HEALTH Corp For: Sep 30 | SEC filing · Form 10-Q | -0.06% | +4.77% |
Keep exploring
More CVS: analyst actions → · SEC filings → · CVS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| GENOMIC HEALTH (GHDX) | 1,111 | 0.00% | 49% |
| INDIVIOR PLC S/ADR (INVVY) | 1,105 | 0.00% | 33% |
| Idera Pharmaceuticals, Inc. (IDRA) | 1,094 | -0.27% | 42% |
| Soleno Therapeutics, Inc. (SLNO) | 1,089 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.